Weight Management
After Stopping a GLP-1: Study Compares 5 Weight Loss Paths
A Cleveland Clinic study of 20,486 patients tracked weight for 2 years after people moved off their first semaglutide or tirzepatide.
U.S.-based company. Licensed U.S. clinicians. U.S.-licensed pharmacy partners. U.S.-based support.
The Avono library
Plain-language articles on treatments, medication quality, safety, regulation and the questions patients actually ask.
Weight Management
A Cleveland Clinic study of 20,486 patients tracked weight for 2 years after people moved off their first semaglutide or tirzepatide.
Hair Loss
In a 45-man trial, the pill combination had the highest hair counts, but the gap versus either drug alone was not significant.
Weight Management
In 13,725 adults, rare GLP1R gene variants were tied to far less weight loss on semaglutide but not on tirzepatide, a new study finds.
Care & Safety
The FDA now requires a warning on all GLP-1 drugs about NAION, a rare cause of vision loss. Here is what its review found.
Skincare
How tretinoin clears acne and helps fade dark spots, why hydroquinone combinations work best for stubborn spots and melasma, which cream fits which problem, and who should not use it.
Weight Management
Tirzepatide and semaglutide both help with weight loss, but they aren’t the same. How they differ, what the head-to-head trial found, and why most people start with tirzepatide.
Skincare
0.025%, 0.05% or 0.1%: what a 48-week trial found about strength and irritation, who each strength suits, how to start and when to move up.
Weight Management
Eight practical steps to feel better and see better results on tirzepatide or semaglutide: dosing, eating, protecting muscle, side effects and staying consistent.
Skincare
How tretinoin works, what the major trials found on fine lines, collagen, sun spots and acne, what it does not do, and who should not use it.
Care & Safety
A vial shows up in the mail. The label says: “Research Use Only.” Maybe the website also says: “Not for Human Consumption.” Then, two inches farther down the…